These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26608119)

  • 1. The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?
    Prasad V; Oseran A; Fakhrejahani F
    Eur J Cancer; 2016 Feb; 54():159-162. PubMed ID: 26608119
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
    Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
    J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raising the profile of cancer of unknown primary.
    Oien KA; Evans TR
    J Clin Oncol; 2008 Sep; 26(27):4373-5. PubMed ID: 18802148
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI.
    Gross-Goupil M; Massard C; Lesimple T; Merrouche Y; Blot E; Loriot Y; Mathieu MC; Fizazi K
    Onkologie; 2012; 35(1-2):54-5. PubMed ID: 22310348
    [No Abstract]   [Full Text] [Related]  

  • 5. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.
    Talantov D; Baden J; Jatkoe T; Hahn K; Yu J; Rajpurohit Y; Jiang Y; Choi C; Ross JS; Atkins D; Wang Y; Mazumder A
    J Mol Diagn; 2006 Jul; 8(3):320-9. PubMed ID: 16825504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling for CUP cancers: are we there yet?
    Varadhachary G
    Onkologie; 2012; 35(1-2):11-2. PubMed ID: 22310338
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary.
    Varadhachary GR; Spector Y; Abbruzzese JL; Rosenwald S; Wang H; Aharonov R; Carlson HR; Cohen D; Karanth S; Macinskas J; Lenzi R; Chajut A; Edmonston TB; Raber MN
    Clin Cancer Res; 2011 Jun; 17(12):4063-70. PubMed ID: 21531815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primary approach to cancers of unknown primary.
    Schwartz AM; Harpaz N
    J Natl Cancer Inst; 2013 Jun; 105(11):759-61. PubMed ID: 23641044
    [No Abstract]   [Full Text] [Related]  

  • 9. Readers' responses to "Cancer of unknown primary site: advances in diagnostics".
    Emmons R; Morris GJ
    Semin Oncol; 2010 Dec; 37(6):555. PubMed ID: 21167373
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
    Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
    Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for carcinoma of unknown primary: the role of tissue-of-origin molecular profiling.
    Varadhachary G
    Clin Cancer Res; 2013 Aug; 19(15):4027-33. PubMed ID: 23519898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
    Dolled-Filhart MP; Rimm DL
    Cancer Cytopathol; 2013 Mar; 121(3):129-35. PubMed ID: 22927160
    [No Abstract]   [Full Text] [Related]  

  • 13. Looks like lung cancer acts like colon cancer.
    Powell M; Pfannl R; Nystrom JS
    Clin Colorectal Cancer; 2013 Jun; 12(2):140-4. PubMed ID: 23083633
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoma of unknown primary: searching for the origin of metastases.
    Carlson HR
    JAAPA; 2009 Aug; 22(8):18-21. PubMed ID: 19725409
    [No Abstract]   [Full Text] [Related]  

  • 15. Microarray analysis as a helpful tool in identifying the primary tumour in cancer with an unknown primary site.
    Soesan M; de Snoo F; Westerga J; Floore A; Bender R
    Neth J Med; 2010 Jan; 68(1):50-1. PubMed ID: 20103826
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinoma of Unknown Primary Site: The Poster Child for Personalized Medicine?
    Varadhachary G
    JAMA Oncol; 2015 Apr; 1(1):19-21. PubMed ID: 26182299
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic evaluation of patients with carcinoma of unknown primary tumor site.
    Leonard RJ; Nystrom JS
    Semin Oncol; 1993 Jun; 20(3):244-50. PubMed ID: 8503020
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of Molecular Profiling in Diagnosis of Papillary Renal-cell Cancer Presenting as Cancer of Unknown Primary Site.
    Nagasaka M; Kukreja G; Abdulfatah E; Vaishampayan U; Sukari A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e713-e717. PubMed ID: 28024951
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical staining and malignancies of unknown primary origin.
    Turney J; Daroca P; Brown J; Jaffe BM
    J La State Med Soc; 2012; 164(2):83-6. PubMed ID: 22685858
    [No Abstract]   [Full Text] [Related]  

  • 20. Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site.
    Garrow GC; Greco FA; Hainsworth JD
    Semin Oncol; 1993 Jun; 20(3):287-91. PubMed ID: 8503025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.